Sonoma Pharmaceuticals (SNOA)
(Delayed Data from NSDQ)
$0.15 USD
0.00 (1.00%)
Updated May 14, 2024 04:00 PM ET
After-Market: $0.15 0.00 (-0.99%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Brokerage Reports
Sonoma Pharmaceuticals, Inc. [SNOA]
Reports for Purchase
Showing records 1 - 8 ( 8 total )
Company: Sonoma Pharmaceuticals, Inc.
Industry: Medical - Drugs
Results for Q2/19 continue positive trend
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: Sonoma Pharmaceuticals, Inc.
Industry: Medical - Drugs
ValuEngine Detailed Valuation Report for SNOA
Provider: ValuEngine, Inc
Company: Sonoma Pharmaceuticals, Inc.
Industry: Medical - Dental Supplies
Revenues lower in Q4/18, but 2019 holds promise
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: Sonoma Pharmaceuticals, Inc.
Industry: Medical - Dental Supplies
Company: Sonoma Pharmaceuticals, Inc.
Industry: Medical - Dental Supplies
Company: Sonoma Pharmaceuticals, Inc.
Industry: Medical - Dental Supplies
SMALL-CAP SQUAWK
Provider: JGR Capital Partners
Company: Sonoma Pharmaceuticals, Inc.
Industry: Medical - Dental Supplies
Company: Sonoma Pharmaceuticals, Inc.
Industry: Medical - Dental Supplies
Oculus Innovative Sciences Announces Name Change
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: GRISEWOOD S
|